Adam J. Funk, Ph.D.
Affiliations: | 2011 | Neurobiology | University of Alabama, Birmingham, Birmingham, AL, United States |
Area:
Neuroscience Biology, Psychobiology PsychologyGoogle:
"Adam Funk"Mean distance: 53433
Parents
Sign in to add mentor| Robert E. McCullumsmith | grad student | 2011 | UAB | |
| (Intracellular signaling abnormalities in schizophrenia.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Alnafisah RS, Reigle J, Eladawi MA, et al. (2022) Assessing the effects of antipsychotic medications on schizophrenia functional analysis: a postmortem proteome study. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology |
| Mielnik CA, Binko MA, Chen Y, et al. (2020) Consequences of NMDA receptor deficiency can be rescued in the adult brain. Molecular Psychiatry |
| Tackie-Yarboi E, Wisner A, Horton A, et al. (2020) Combining Neurobehavioral Analysis and In Vivo Photoaffinity Labeling to Understand Protein Targets of Methamphetamine in Casper Zebrafish. Acs Chemical Neuroscience |
| Bentea E, Villers A, Moore C, et al. (2020) Corticostriatal dysfunction and social interaction deficits in mice lacking the cystine/glutamate antiporter. Molecular Psychiatry |
| Moody CL, Funk AJ, Devine E, et al. (2020) Adenosine Kinase Expression in the Frontal Cortex in Schizophrenia. Schizophrenia Bulletin. 46: 690-698 |
| Sullivan CR, Mielnik CA, Funk A, et al. (2019) Measurement of lactate levels in postmortem brain, iPSCs, and animal models of schizophrenia. Scientific Reports. 9: 5087 |
| Lara O, Bentea E, Villers A, et al. (2019) The cystine/glutamate antiporter system xc- as modulator of corticostriatal neurotransmission Frontiers in Neuroscience. 13 |
| Sullivan CR, Mielnik CA, O'Donovan SM, et al. (2018) Connectivity Analyses of Bioenergetic Changes in Schizophrenia: Identification of Novel Treatments. Molecular Neurobiology |
| Funk A, Greis K, Meller J, et al. (2018) 32.2 ABNORMALITIES OF SYNAPTIC PROTEOMES IN SCHIZOPHRENIA Schizophrenia Bulletin. 44: S52-S53 |
| Funk A, Mielnik C, O’Donovan S, et al. (2018) 12.2 METABOLIC CONSEQUENCES OF DEVELOPMENTAL NMDA RECEPTOR HYPOFUNCTION Schizophrenia Bulletin. 44: S19-S20 |